SCHEMBL697932

SCHEMBL697932

Cc1cc(C)c(COC(=O)n2ccnc2[C@@H](C)c2cccc(C)c2C)c(C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
POLB P06746 1/20 0.33
FFAR1 O14842 3/20 0.33
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 3/20 0.31
GRIN2B Q13224 1/20 0.31
ALDH1A1 P00352 3/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
MAPT P10636 1/20 0.30
ADRA2A P08913 2/20 0.30
ADRA2B P18089 2/20 0.30
ADRA2C P18825 2/20 0.30
ADRA1D P25100 2/20 0.30
ADRA1A P35348 2/20 0.30
ADRA1B P35368 2/20 0.30
KCNH2 Q12809 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL696474 0.91 LMNA (0.34) LMNAPOLBFFAR1MEN1KMT2A
SCHEMBL696420 0.90 LMNA (0.35) LMNAPOLBFFAR1MEN1KMT2A
SCHEMBL697358 0.90 LMNA (0.33) LMNAPOLBFFAR1MEN1KMT2A
SCHEMBL697782 0.90 GRIN2B (0.35) LMNAPOLBFFAR1MEN1KMT2A
SCHEMBL698585 0.88 KDM4A (0.36) LMNAPOLBFFAR1MEN1KMT2A
SCHEMBL697665 0.88 LMNA (0.33) LMNAPOLBFFAR1TDP1MEN1
SCHEMBL697841 0.88 MMP1 (0.33) LMNAPOLBFFAR1TDP1MEN1
SCHEMBL697604 0.88 GUCY1B2 (0.37) TDP1MEN1KMT2AKDM4EGRIN2B
SCHEMBL698376 0.88 ALDH1A1 (0.37) FFAR1TDP1KMT2AKDM4EALDH1A1
SCHEMBL699093 0.87 ALDH1A1 (0.40) LMNAPOLBMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885POLB 3099/4885FFAR1 4603/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885POLB 3099/4885FFAR1 4603/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885POLB 3099/4885FFAR1 4603/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885POLB 3099/4885FFAR1 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.